DIANA VITALE: Open Payments
NPI 1265969349 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 47 payments from 12 companies in 2025. Trend: 2023 $1,785 · 2024 $1,590 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $268 |
| Corium, LLC | 9 | $135 |
| Noven Therapeutics, LLC | 5 | $101 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $34 |
Products named: CAPLYTA, Azstarys, Xelstrym, REXULTI, Qelbree, Auvelity, VRAYLAR, Jornay PM.
Industry payments across MI — which companies pay providers there.
